The US has developed a “double test”: for influenza and COVID-19

In the United States, in parallel with the development of the Covid-19 vaccine, other studies are underway to detect and diagnose respiratory diseases.

The US Food and Drug Administration (FDA) has approved a new test that can detect an unknown source of the disease, like the flu and the coronavirus, in a patient with a respiratory tract infection, reports.

Medical experts fear that in the fall, along with the advent of seasonal flu, hospitals will face a double threat – as patients with both the flu and the coronavirus will get there. The symptoms of these two diseases are very similar, but Covid-19 is more contagious.

In order to quickly diagnose respiratory diseases, the Center for Disease Control and Prevention in the USA (CDC) has developed the first “double” test that can detect infection with both the flu and the coronavirus.

A statement from federal agency commissioner Stephen Khan says:

“By allowing the use of these tests, the FDA helps address concerns about the possible coming of the flu season during the Covid-19 pandemic, which may be of particular concern to Americans.” He continues: “Using a simple wand or probe, combined tests can be used to make Americans more likely to find out the answer (to the question, what they get sick – ed.).”

“In the longer term, this effectiveness will help confirm the information received on time for patients suffering from an unidentified disease of the respiratory system,” S. Khan explains.

As you know, the United States of America is currently the most affected pandemic state in the world. Over 2.7 million people with a diagnosis of Covid-19 have already been recorded here, and as a result of coronavirus disease, 128 thousand 740 people have already died.

The “double” test, which will be delivered to US hospitals before the fall, gives hope that timely diagnosis of influenza and coronavirus will allow faster treatment of infected people, and therefore save thousands of lives.

However, the federal agency’s report did not say whether United States physicians would share their discovery with the rest of the world.